title: Plasmodium falciparum infection is associated with Epstein-Barr virus reactivation in pregnant women living in malaria holoendemic area of Western Kenya.
abstract: The role of Plasmodium falciparum malaria in Epstein-Barr virus (EBV) transmission among infants early in life remain elusive. We hypothesized that infection with malaria during pregnancy could cause EBV reactivation leading to high EBV load in circulation, which could subsequently enhance early age of EBV infection. Pregnant women in Kisumu, where P. falciparum malaria is holoendemic, were actively followed monthly through antenatal visits (up to 4 per mother) and delivery. Using real-time quantitative (Q)-PCR, we quantified and compared EBV and P. falciparum DNA levels in the blood of pregnant women with and without P. falciparum malaria. Pregnant women that had malaria detected during pregnancy were more likely to have detectable EBV DNA than pregnant women who had no evidence of malaria infection during pregnancy (64 vs. 36 %, p = 0.01). EBV load as analyzed by quantifying area under the longitudinal observation curve (AUC) was significantly higher in pregnant women with P. falciparum malaria than in women without evidence of malaria infection (p = 0.01) regardless of gestational age of pregnancy. Increase in malaria load correlated with increase in EBV load (p < 0.0001). EBV load was higher in third trimester (p = 0.04) than first and second trimester of pregnancy independent of known infections. Significantly higher frequency and elevated EBV loads were found in pregnant women with malaria than in women without evidence of P. falciparum infection during pregnancy. The loss of control of EBV latency following P. falciparum infection during pregnancy and subsequent increase in EBV load in circulation could contribute to enhanced shedding of EBV in maternal saliva and breast milk postpartum, but further studies are needed.
authors.affiliation: Center for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.
authors.forename: Ibrahim I
authors.initials: II
authors.lastname: Daud
authors.forename: Sidney
authors.initials: S
authors.lastname: Ogolla
authors.forename: Asito S
authors.initials: AS
authors.lastname: Amolo
authors.forename: Eunice
authors.initials: E
authors.lastname: Namuyenga
authors.forename: Kenneth
authors.initials: K
authors.lastname: Simbiri
authors.forename: Elizabeth A
authors.initials: EA
authors.lastname: Bukusi
authors.forename: Zipporah W
authors.initials: ZW
authors.lastname: Ng'ang'a
authors.forename: Robert
authors.initials: R
authors.lastname: Ploutz-Snyder
authors.forename: Peter O
authors.initials: PO
authors.lastname: Sumba
authors.forename: Arlene
authors.initials: A
authors.lastname: Dent
authors.forename: Rosemary
authors.initials: R
authors.lastname: Rochford
mesh_terms: D000328:Adult; D016054:DNA, Protozoan / Q000097:blood; D004279:DNA, Viral / Q000097:blood*; D020031:Epstein-Barr Virus Infections / Q000097:blood / Q000150:complications; D005260:Female; D004854:Herpesvirus 4, Human / Q000235:genetics*; D006801:Humans; D016778:Malaria, Falciparum / Q000097:blood* / Q000150:complications; D018512:Parasitemia; D010963:Plasmodium falciparum / Q000235:genetics*; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000097:blood*; D037841:Pregnant People; D060888:Real-Time Polymerase Chain Reaction; D019562:Viral Load
chemical_list: D016054:DNA, Protozoan; D004279:DNA, Viral